Literature DB >> 21603031

Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease.

Iliana Doycheva1, Chaoru Chen, Jen-Jung Pan, Cynthia Levy.   

Abstract

AIM: To estimate the prevalence of cardiovascular events in Primary biliary cirrhosis (PBC) and to determine whether this risk is higher within specific subgroups of patients with PBC.
METHODS: We included 180 patients with PBC (cases) and 151 patients seen for HCV infection (controls). Medical records were reviewed and statistical analyses were performed as appropriate.
RESULTS: When compared to controls, PBC patients were older, leaner and had higher serum levels of total cholesterol, high density lipoprotein and low density cholesterol. There were more females in the PBC group (91.7% vs 43%, P < 0.001). More control subjects had smoked than the PBC patients (63.6% vs 35%, P < 0.001). The prevalence of hypertension, diabetes, coronary artery disease and stroke was similar between the two groups. Seven percent of controls and 10% of cases developed any type of cardiovascular disease (P = 0.3). Only 36.7% were asymptomatic at diagnosis. Three cardiovascular events were documented among asymptomatic patients (4.5%) and fifteen among symptomatic patients (13.2%; P = 0.06). Among PBC patients with fatigue, 10 (13.5%) had a cardiovascular event compared to 7 (6.7%) among patients without fatigue (P = 0.1).
CONCLUSION: Asymptomatic PBC patients do not have a greater frequency of cardiovascular disease; nor do patients suffering with fatigue.

Entities:  

Keywords:  Asymptomatic primary biliary cirrhosis; Cardiovascular disease; Fatigue; Hyperlipidemia

Year:  2011        PMID: 21603031      PMCID: PMC3098393          DOI: 10.4254/wjh.v3.i4.93

Source DB:  PubMed          Journal:  World J Hepatol


  20 in total

1.  Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.

Authors:  P Angulo; K D Lindor; T M Therneau; R A Jorgensen; M Malinchoc; P S Kamath; E R Dickson
Journal:  Liver       Date:  1999-04

2.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.

Authors:  J Pekkanen; S Linn; G Heiss; C M Suchindran; A Leon; B M Rifkind; H A Tyroler
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

3.  Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.

Authors:  C E Jahn; E J Schaefer; L A Taam; J H Hoofnagle; F T Lindgren; J J Albers; E A Jones; H B Brewer
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

4.  An exploratory population-based case-control study of primary biliary cirrhosis.

Authors:  D Howel; C M Fischbacher; R S Bhopal; J Gray; J V Metcalf; O F James
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

5.  Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics.

Authors:  H Gylling; M Färkkilä; M Vuoristo; T A Miettinen
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

Review 6.  Primary biliary cirrhosis.

Authors:  Jayant A Talwalkar; Keith D Lindor
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

7.  Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up.

Authors:  Einar Björnsson; Evangelos Kalaitzakis; Matthias Neuhauser; Felicity Enders; Hardy Maetzel; Roger W Chapman; Jayant Talwalkar; Keith Lindor; Roberta Jorgensen
Journal:  Liver Int       Date:  2009-11-17       Impact factor: 5.828

8.  Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.

Authors:  V Balan; E R Dickson; R A Jorgensen; K D Lindor
Journal:  Mayo Clin Proc       Date:  1994-10       Impact factor: 7.616

9.  Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.

Authors:  M Longo; A Crosignani; P M Battezzati; C Squarcia Giussani; P Invernizzi; M Zuin; M Podda
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

10.  Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis.

Authors:  Julia L Newton; Mark Hudson; Phaedra Tachtatzis; Kathryn Sutcliffe; Jessie Pairman; Jennifer A Burt; David E J Jones
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

View more
  4 in total

1.  Risk of incident coronary artery disease in patients with primary biliary cirrhosis.

Authors:  Chunya Wang; Pan Zhao; Weiwei Liu
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 2.  Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy.

Authors:  Martin I Wah-Suarez; Christopher J Danford; Vilas R Patwardhan; Z Gordon Jiang; Alan Bonder
Journal:  Frontline Gastroenterol       Date:  2019-01-09

3.  Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review.

Authors:  Duminda Suraweera; Christina Fanous; Melissa Jimenez; Myron J Tong; Sammy Saab
Journal:  J Clin Transl Hepatol       Date:  2018-02-14

4.  Primary biliary cholangitis presenting as acute ischemic stroke: A rare association.

Authors:  Bumsoo Park; Sumaiya Islam; Raghavendra C Vemulapalli; Maria E Shreve
Journal:  Clin Case Rep       Date:  2020-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.